Leopold, MD, explains how evidence-based integrative therapies like acupuncture and nutrition improve oncology patient ...

Practical examples of advanced practice provider–led initiatives that improve safety, symptom management, and patient ...

The FDA updated its safety labeling for capecitabine and 5-FU to reflect that patients with certain genetic variants risk ...

Emese Zsiros, MD, PhD, FACOG, discusses managing paclitaxel toxicity and the role of pembrolizumab maintenance in treating platinum-resistant ovarian cancer.

The FDA has approved Optune Pax, a wearable medical device that delivers Tumor Treating Fields (TTFields), for the treatment of adult patients with locally advanced pancreatic cancer (LA-PAC) ...

Rinatabart sesutecan (Rina-S) demonstrated a 100% disease control rate at the 100-mg/m 2 dose for patients with heavily ...

Jakel shared the story of a young mother who had been deemed difficult and “in denial” by other staff due to her rejecting ...

The advantage of MCED testing is its potential to identify cancers at earlier, more treatable stages; detecting cancer even ...

An advocate is not the same as a health care proxy who is assigned to speak for a patient on their advanced directives.

RMAT status for KB707 enables expedited development with enhanced FDA engagement, supported by early KYANITE-1 activity and durability in heavily pretreated advanced/metastatic NSCLC. LungTIME-C01 ...